2019

Hier vindt u een chronologisch overzicht van wetenschappelijke publicaties in 2019, gepubliceerd door de klinische onderzoeksgroepen die betrokken zijn bij ATHENA/SHM

Pre-exposure prophylaxis for MSM in the Netherlands: impact on HIV and N. gonorrhoeae transmission and cost-effectiveness
Reitsema M, Van Hoek AJ, Van Der Loeff MS, Hoornenborg E, Van Sighem A, Wallinga J, Van Benthem B, Xiridou M. 
AIDS. 2019 Dec 27. doi: 10.1097/QAD.0000000000002469. [Epub ahead of print]

Impact of frequent testing on the transmission of HIV and N. gonorrhoeae among men who have sex with men: a mathematical modelling study
Reitsema M, Heijne J, Visser M, van Sighem A, Schim van der Loeff M, Op de Coul ELM, Bezemer D, Wallinga J, van Benthem BHB, Xiridou M. 
Sex Transm Infect. 2019 Dec 4. pii: sextrans-2018-053943. doi: 10.1136/sextrans-2018-053943. [Epub ahead of print]

Parameter estimates for trends and patterns of excess mortality among persons on antiretroviral therapy in high-income European settings
Trickey A, van Sighem A, Stover J, Abgrall S, Grabar S, Bonnet F, Berenguer J, Wyen C, Casabona J, d'Arminio Monforte A, Cavassini M, Del Amo J, Zangerle R, Gill MJ, Obel N, Sterne JAC, May MT.
AIDS. 2019 Dec 15;33 Suppl 3:S271-S281. doi: 10.1097/QAD.0000000000002387.

Lower IQ and poorer cognitive profiles in treated perinatally HIV-infected children is irrespective of having a background of international adoption
Van den Hof M, Ter Haar AM, Scherpbier HJ, Reiss P, Wit FWNM, Oostrom KJ, Pajkrt D
PLoS One. 2019 Dec 5;14(12):e0224930. doi: 10.1371/journal.pone.0224930. eCollection 2019.

Immune reconstitution inflammatory syndrome in HIV late presenters starting integrase inhibitor containing antiretroviral therapy
Wijting IEA, Wit FWNM, Rokx C, Leyten EMS, Lowe SH, Brinkman K, Bierman WFW, van Kasteren MEE, Postma AM, Bloemen VCM, Bouchtoubi G, Hoepelman AIM, van der Ende ME, Reiss P, Rijnders BJA; ATHENA national observational HIV cohort.
EClinicalMedicine. 2019 Dec 13;17:100210. doi: 10.1016/j.eclinm.2019.11.003. eCollection 2019 Dec.

Is reaching 90-90-90 enough to end AIDS? Lessons from Amsterdam
de Bree GJ, van Sighem A, Zuilhof W, van Bergen JEAM, Prins M, Heidenrijk M, van der Valk M, Brokx P, Reiss P; HIV Transmission Elimination AMsterdam (H-TEAM) Initiative.
Curr Opin HIV AIDS. 2019 Nov;14(6):455-463. doi: 10.1097/COH.0000000000000586.

Effectiveness of transmitted drug resistance testing before initiation of antiretroviral therapy in HIV-positive individuals
Lodi S, Günthard HF, Gill J, Phillips AN, Dunn D, Vu Q, Siemieniuk R, Garcia F, Logan R, Jose S, Bucher HC, Scherrer AU, Reiss P, van Sighem A, Boender TS, Porter K, Gilson R, Paraskevis D, Simeon M, Vourli G, Moreno S, Jarrin I, Sabin C, Hernán M.
J Acquir Immune Defic Syndr. 2019 Nov 1;82(3):314-320. doi: 10.1097/QAI.0000000000002135.

The EuroSIDA study: 25 years of scientific achievements
Laut K, Kirk O, Rockstroh J, et al.
HIV Medicine 2019 Oct 24. doi: 10.1111/hiv.12810. [Epub ahead of print]

Incidence and risk factors for invasive pneumococcal disease and community-acquired pneumonia in human immunodeficiency virus-infected individuals in a high-income setting
Garcia Garrido HM, Mak AMR, Wit FWNM, Wong GWM, Knol MJ, Vollaard A, Tanck MWT, Van Der Ende A, Grobusch MP, Goorhuis A. 
Clin Infect Dis. 2019 Oct 21. pii: ciz728. doi: 10.1093/cid/ciz728.

Height and timing of growth spurt during puberty in young people living with vertically acquired HIV in Europe and Thailand
European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) study group.
AIDS. 2019 Oct 1;33(12):1897-1910. doi: 10.1097/QAD.0000000000002294. 

Disparities in access to and use of HIV-related health services in the Netherlands by migrant status and sexual orientation: a cross-sectional study among people recently diagnosed with HIV infection
Bil JP, Zuure FR, Alvarex-del Arco D, Prins JM, Brinkman K, Leyten E, van Sighem A, Burns F, Prins M
BMC Infect Dis 19, 906 (2019) doi:10.1186/s12879-019-4477-2

Predictors of ischemic and hemorrhagic strokes among people living with HIV: the D:A:D international prospective multicohort study
Hatleberg CI, Ryom L, Kamara D, De Wit S, Law M, Phillips A, Reiss P, D’Arminio Monforte A, Mocroft A, Pradier C, Kirk O, Kovari H, Bonnet F,  El-Sadr W, Lundgren JD, Sabin C for the D:A:D Study Group*
EClinicalMedicine. 2019 Aug 11;13:91-100. doi: 10.1016/j.eclinm.2019.07.008. eCollection 2019 Aug.

Serious clinical events in HIV-positive persons with chronic kidney disease (CKD).
Ryom L, Lundgren JD, Law M, Kirk O, El-Sadr W, Bonnet F, Weber R, Fontas E, Monforte AD, Phillips A, Reiss P, de Wit S, Hatleberg CI, Sabin C, Mocroft A; D:A:D study group.
AIDS. 2019 Aug 2. doi: 10.1097/QAD.0000000000002331. [Epub ahead of print]

Longitudinal virological outcomes and factors associated with virological failure in behaviourally HIV-infected young adults on combination antiretroviral treatment in the Netherlands, 2000-2015
Weijsenfeld AM, Blokhuis C, Stuiver MM, Wit FWNM, Pajkrt D; ATHENA observational HIV cohort.
Medicine (Baltimore). 2019 Aug;98(32):e16357. doi: 10.1097/MD.0000000000016357.

CD4 recovery following antiretroviral treatment interruptions in children and adolescents with HIV infection in Europe and Thailand
European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) Study Group in EuroCoord.
HIV Med. 2019 Aug;20(7):456-472. 

Emulating a trial of joint dynamic strategies: An application to monitoring and treatment of HIV-positive individuals
Caniglia EC, Robins JM, Cain LE, Sabin C, Logan R, Abgrall S, Mugavero MJ, Hernández-Díaz S, Meyer L, Seng R, Drozd DR, Seage Iii GR, Bonnet F, Le Marec F, Moore RD, Reiss P, van Sighem A, Mathews WC, Jarrín I, Alejos B, Deeks SG, Muga R, Boswell SL, Ferrer E, Eron JJ, Gill J, Pacheco A, Grinsztejn B, Napravnik S, Jose S, Phillips A, Justice A, Tate J, Bucher HC, Egger M, Furrer H, Miro JM, Casabona J, Porter K, Touloumi G, Crane H, Costagliola D, Saag M, Hernán MA
Stat Med. 2019 Jun 15;38(13):2428-2446. doi: 10.1002/sim.8120. Epub 2019 Mar 18. 

Predictors of faster virological suppression in early treated infants with perinatal HIV from Europe and Thailand
European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) and Early-treated Perinatally HIV-infected Individuals: Improving Childrenʼs Actual Life with Novel Immunotherapeutic Strategies (EPIICAL) study groups. 
AIDS. 2019 Jun 1;33(7):1155-1165. doi: 10.1097/QAD.0000000000002172. 

Neurocognitive development in perinatally HIV-infected adolescents on long-term treatment compared to healthy matched controls: a longitudinal study
Van den Hof M, Ter Haar AM, Scherpbier HJ, van der Lee JH, Reiss P, Wit FWNM, Oostrom KJ, Pajkrt D.
Clin Infect Dis. 2019 May 18. pii: ciz386. doi: 10.1093/cid/ciz386. [Epub ahead of print]

Validation of a novel multivariate method of defining HIV-associated cognitive impairment
Underwood J, De Francesco D, Cole JH, Caan MWA, van Zoest RA, Schmand BA, Sharp DJ, Sabin CA, Reiss P, Winston A; COmorBidity in Relation to AIDS (COBRA) Collaboration and the Pharmacokinetic and clinical Observations in PePle over fiftY (POPPY) Study Group.​​​​​​​
Open Forum Infect Dis. 2019 May 3;6(6):ofz198. doi: 10.1093/ofid/ofz198. eCollection 2019 Jun.

Low compliance with hepatocellular carcinoma screening guidelines in hepatitis B/C virus co-infected HIV-patients with cirrhosis
Willemse S, Smit C, Sogni P, Sarcletti M, Uberti-Foppa C, Wittkop L, Raben D, D'Arminio Monforte A, Dabis F, Van Der Valk M; Hepatocellular Carcinoma Screening Project Working Group for the Collaboration of Observational HIV on behalf of Epidemiological Research Europe (COHERE) In EuroCoord.
J Viral Hepat. 2019 May 28. doi: 10.1111/jvh.13146. [Epub ahead of print]

Incidence of hepatocellular carcinoma in HIV/HBV-coinfected patients on tenofovir therapy: Relevance for screening strategies
Wandeler G, Mauron E, Atkinson A, Dufour JF, Kraus D, Reiss P, Peters L, Dabis F, Fehr J, Bernasconi E, van der Valk M, Smit C, Gjærde LK, Rockstroh J, Neau D, Bonnet F, Rauch A; Swiss HIV Cohort Study, Athena Observational Cohort Study, EuroSIDA, ANRS CO3 Aquitaine Cohort.
J Hepatol. 2019 Apr 6. pii: S0168-8278(19)30226-0. doi: 10.1016/j.jhep.2019.03.032. [Epub ahead of print]

Evaluating progress towards triple elimination of mother-to-child transmission of HIV, syphilis and hepatitis B in the Netherlands
Visser M, van der Ploeg CPB, Smit C, Hukkelhoven CWPM, Abbink F, van Benthem BHB, Op de Coul ELM.
BMC Public Health. 2019 Mar 29;19(1):353. doi: 10.1186/s12889-019-6668-6.

Prevalence and clinical outcomes of poor immune response despite virologically suppressive antiretroviral therapy among children and adolescents with HIV in Europe and Thailand: cohort study
European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) study group in EuroCoord​​​​​​​
Clin Infect Dis. 2019  Mar 28. pii: ciz253. doi: 10.1093/cid/ciz253. [Epub ahead of print] 

Long-term virological suppression on first-line efavirenz  + tenofovir  + emtricitabine / lamivudine for HIV-1
Long-Term Virological Suppression Working Group for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord. ​​​​​​​
AIDS. 2019 Mar 15;33(4):745-751. doi: 10.1097/QAD.0000000000002126.

Effect estimates in randomized trials and observational studies: comparing apples with apples
Lodi S, Phillips A, Lundgren J, Logan R, Sharma S, Cole SR, Babiker A, Law M, Chu H, Byrne D, Horban A, Sterne JAC, Porter K, Sabin C, Costagliola D, Abgrall S, Gill J, Touloumi G, Pacheco AG, van Sighem A, Reiss P, Bucher HC, Montoliu Giménez A, Jarrin I, Wittkop L, Meyer L, Perez-Hoyos S, Justice A, Neaton JD, Hernán MA; INSIGHT START Study Group and the HIV-CAUSAL Collaboration.
Am J Epidemiol. 2019 May 7. pii: kwz100. doi: 10.1093/aje/kwz100. [Epub ahead of print]

Piloting a surveillance system for HIV drug resistance in the European Union
van de Laar MJ, Bosman A, Pharris A, Andersson E, Assoumou L, Ay E, Bannert N, Bartmeyer B, Brady M, Chaix ML, Descamps D, Dauwe K, Fonager J, Hauser A, Lunar M, Mezei M, Neary M, Poljak M, van Sighem A, Verhofstede C, Amato-Gauci AJ, Broberg EK.
Euro Surveill. 2019 May;24(19). doi: 10.2807/1560-7917.ES.2019.24.19.1800390.

Predictive performance of cardiovascular disease risk prediction algorithms in people living with HIV
Van Zoest RA, Law M, Sabin CA, Vaartjes I, Van Der Valk M, Arends JE, Reiss P, Wit FW.
J Acquir Immune Defic Syndr. 2019 Apr 23. doi: 10.1097/QAI.0000000000002069. [Epub ahead of print]

Emulating a trial of joint dynamic strategies: An application to monitoring and treatment of HIV-positive individuals
Caniglia EC, Robins JM, Cain LE, Sabin C, Logan R, Abgrall S, Mugavero MJ, Hernández-Díaz S, Meyer L, Seng R, Drozd DR, Seage Iii GR, Bonnet F, Le Marec F, Moore RD, Reiss P, van Sighem A, Mathews WC, Jarrín I, Alejos B, Deeks SG, Muga R, Boswell SL, Ferrer E, Eron JJ, Gill J, Pacheco A, Grinsztejn B, Napravnik S, Jose S, Phillips A, Justice A, Tate J, Bucher HC, Egger M, Furrer H, Miro JM, Casabona J, Porter K, Touloumi G, Crane H, Costagliola D, Saag M, Hernán MA.
Stat Med. 2019 Jun 15;38(13):2428-2446. doi: 10.1002/sim.8120. Epub 2019 Mar 18.

Challenges in modelling the proportion of undiagnosed HIV infections in Sweden
Andersson E, Nakagawa F, van Sighem A, Axelsson M, Phillips AN, Sönnerborg A, Albert J.
Euro Surveill. 2019;24(14):pii=1800203 

Incidence of hepatocellular carcinoma in HIV/HBV-coinfected patients on tenofovir therapy: Relevance for screening strategies
Wandeler G, Mauron E, Atkinson A, Dufour JF, Kraus D, Reiss P, Peters L, Dabis F, Fehr J, Bernasconi E, van der Valk M, Smit C, Gjærde LK, Rockstroh J, Neau D, Bonnet F, Rauch A; Swiss HIV Cohort Study, Athena Observational Cohort Study, EuroSIDA, ANRS CO3 Aquitaine Cohort.
J Hepatol. 2019 Apr 6. pii: S0168-8278(19)30226-0. doi: 10.1016/j.jhep.2019.03.032. [Epub ahead of print]

Albumin, white blood cell count, and body mass index improve discrimination of mortality in HIV-positive individuals
Tate JP, Sterne JAC, Justice AC; Veterans Aging Cohort Study (VACS) and the Antiretroviral Therapy Cohort Collaboration (ART-CC).
AIDS. 2019 Apr 1;33(5):903-912. doi: 10.1097/QAD.0000000000002140 

Cost-effectiveness of increased hiv testing among men who have sex with men in the netherlands
Reitsema M, Steffers L, Visser M, Heijne J, Hoek AJV, Loeff MSV, Van Sighem A, Van Benthem B, Wallinga J, Xiridou M, Mangen MJ.
AIDS. 2019 Mar 15. doi: 10.1097/QAD.0000000000002199. [Epub ahead of print]

Emulating a trial of joint dynamic strategies: An application to monitoring and treatment of HIV-positive individuals
Caniglia EC, Robins JM, Cain LE, Sabin C, Logan R, Abgrall S, Mugavero MJ, Hernández-Díaz S, Meyer L, Seng R, Drozd DR, Seage Iii GR, Bonnet F, Le Marec F, Moore RD, Reiss P, van Sighem A, Mathews WC, Jarrín I, Alejos B, Deeks SG, Muga R, Boswell SL, Ferrer E, Eron JJ, Gill J, Pacheco A, Grinsztejn B, Napravnik S, Jose S, Phillips A, Justice A, Tate J, Bucher HC, Egger M, Furrer H, Miro JM, Casabona J, Porter K, Touloumi G, Crane H, Costagliola D, Saag M, Hernán MA.
Stat Med. 2019 Mar 18. doi: 10.1002/sim.8120. [Epub ahead of print] 

Efficacy and safety of long-term maraviroc use in a heterogeneous group of HIV-infected patients: a retrospective cohort study
Weehuizen JM, Wensing AMJ, Mudrikova T, Wit FWNM, Hoepelman AIM.
Int J Antimicrob Agents. 2019 Mar 1. pii: S0924-8579(19)30048-2. doi: 10.1016/j.ijantimicag.2019.02.018. [Epub ahead of print]

Predicting virological response to HIV treatment over time: a tool for settings with different definitions of virological response
Revell AD, Wang D, Perez-Elias MJ, Wood R, Tempelman H, Clotet B, Reiss P, van Sighem AI, Alvarez-Uria G, Nelson M, Montaner JS, Lane HC, Larder BA.
J Acquir Immune Defic Syndr. 2019 Feb 14. doi: 10.1097/QAI.0000000000001989. [Epub ahead of print]

Incidence of a first thrombotic event in people with HIV in the Netherlands: a retrospective cohort study
Borjas Howard JF, Rokx C, Smit C, Wit FWNM, Pieterman ED, Meijer K, Rijnders B, Bierman WFW, Vladimir Tichelaar YIG, on behalf of ATHENA observational HIV cohort investigators
The Lancet HIV, published online February 15 2019; DOI:https://doi.org/10.1016/S2352-3018(18)30333-3

Phylogenies from dynamic networks
Metzig C, Ratmann O, Bezemer D, Colijn C.
PLoS Comput Biol. 2019 Feb; 15(2): e1006761.

Incidence of switching to second-line antiretroviral therapy and associated factors in children with HIV: an international cohort collaboration
Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Global Cohort Collaboration. ​​​​​​​
Lancet HIV. 2019 Feb;6(2):e105-e115. doi:10.1016/S2352-3018(18)30319-9.  

Progression of liver fibrosis following acute hepatitis C virus infection in HIV-positive MSM
Newsum AM, Kooij KW, Boyd A, Smit C, Wit FWNM, van der Meer JTM, Prins M, Reiss P, van der Valk M; MOSAIC study group, ATHENA observational HIV cohort and NVHB-SHM hepatitis working group.
AIDS. 2019 Jan 14. doi: 10.1097/QAD.0000000000002138. [Epub ahead of print]

Compliance with laboratory monitoring guidelines in outpatient HIV care: a qualitative study in the Netherlands
Toxopeus DCM, Pell CL, Westrhenen NB, Smit C, Wit FWNM, Ondoa P, Reiss P, Boender TS.
AIDS Care. 2019 Jan 2:1-8. doi: 10.1080/09540121.2018.1563280. [Epub ahead of print]